Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Briac Guibourg
Costs of ALK , ROS1 , EGFR , and KRAS Testing in Non-Small Cell Lung Cancer: About Different Strategies in France
Cancer cytopathology
Cancer Research
Oncology
Related publications
Reply to Costs of ALK , ROS1 , EGFR , and KRAS Testing in Non-Small Cell Lung Cancer: About Different Strategies in France
Cancer cytopathology
Cancer Research
Oncology
ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
Oncology in Clinical Practice
Oncology
Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
PLoS ONE
Multidisciplinary
KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
446 Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
European Journal of Cancer
Cancer Research
Oncology
Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology